Notice of Supplemental Funding for Regional Pediatric Pandemic Network Award Recipients, 65638-65639 [2024-17821]
Download as PDF
<![CDATA[
65638
Federal Register / Vol. 89, No. 155 / Monday, August 12, 2024 / Notices
Act (Pub. L. 116–127); and the
American Rescue Plan Act of 2021 (Pub.
L. 117–2) provided the Department of
Health and Human Services the
authority to administer the Provider
Relief Programs (PRP) (i.e., Provider
Relief Fund; American Rescue Plan Act
Rural Distribution; COVID–19 Coverage
Assistance Fund; and COVID–19 Claims
Reimbursement to Health Care
Providers and Facilities for Testing,
Treatment, and Vaccine Administration
for the Uninsured). The Department of
Health and Human Services, through
HRSA, administered the PRP. The PRP
issued payments to eligible health care
providers for expenses or lost revenues
attributable to COVID–19 and claims
reimbursement for COVID–19 testing,
treatment, and vaccine administration
for uninsured individuals. Recipients of
these funds agreed to the Terms and
Conditions applicable to each Program,
which require, among other Terms,
compliance with reporting requirements
as specified by the Secretary of Health
and Human Services and the statues
listed above. Recipients are eligible
health care providers who include
public entities, Medicare or Medicaid
enrolled suppliers and providers, and
for-profit and non-profit entities that
provide diagnosis, testing, vaccination,
or care for individuals with possible or
actual cases of COVID–19. The Single
Audit Act requires entities that expend
$750,000 or more of federal assistance
during the entity’s fiscal year to conduct
an independent audit. Requirements for
these audits are set forth in regulations
at 45 CFR Subpart F. Requirements
differ for non-profit and commercial/forprofit entities, and non-profit entities
are required to submit their audits to the
Federal Audit Clearinghouse. HRSA has
established a Commercial Audit
Reporting Portal to collect audits from
commercial/for-profit organizations. In
late calendar year 2023, HRSA
developed a delinquent audit follow-up
process to ensure that all providers
required to submit an audit do so. The
delinquent audit follow-up process
includes educating PRP recipients on
the 45 CFR 75 Subpart F requirements
and following up on overdue audit
report submissions. In February 2024,
OMB approved HRSA’s emergency ICR
for the Commercial Audit Reporting
Portal and the delinquent audit followup process. Collectively, these activities
will help ensure the fiscal and program
integrity of the PRP.
A 60-day notice published in the
Federal Register on May 2, 2024, vol.
89, No. 86; pp. 35842–35843. There
were no public comments.
Need and Proposed Use of the
Information: HRSA will use the
collected information to ensure all PRP
recipients who expended over $750,000
in funding during the recipient’s fiscal
year submit an audit and resolve audit
findings, which may include recovery of
any funds used not in accordance with
the Terms and Conditions of the
programs.
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total
burden
hours
Provider Relief Bureau Commercial Audit Reporting Portal
Commercial Audit Compliance Email ..................................
Delinquent Audit Follow-up General Email Blast and Attestation .................................................................................
Delinquent Audit Follow-up Targeted Email and Attestation
Questioned Cost Attestation ................................................
21,000
500
1
1
21,000
500
0.75
0.25
15,750
125
42,000
21,000
7,000
6
2
10
252,000
42,000
70,000
0.25
0.25
5.00
63,000
10,500
350,000
Total ..............................................................................
91,500
........................
385,500
........................
439,375
Maria G. Button,
Director, Executive Secretariat.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–17907 Filed 8–9–24; 8:45 am]
BILLING CODE 4165–15–P
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Likely Respondents: PRP recipients
who expended over $750,000 in funding
during their fiscal year.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
The February 2024 emergency ICR
also included the Commercial Audit
Compliance and Delinquent Audit
Follow-up General and Targeted emails,
which will continue to be used. These
burden hours associated with these
emails were erroneously left out of
burden table in the 60-day notice and
have been added back into the 30-day
Federal Register notice. The Delinquent
Audit Follow-up General Email Blast
was also updated to include more
details regarding audit requirements for
PRP payments.
Total Estimated Annualized Burden
Hours:
Health Resources and Services
Administration
Notice of Supplemental Funding for
Regional Pediatric Pandemic Network
Award Recipients
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
ACTION:
VerDate Sep<11>2014
17:30 Aug 09, 2024
Jkt 262001
PO 00000
Notice of supplemental funding.
Frm 00058
Fmt 4703
Sfmt 4703
Per Congressional Report
language accompanying the Further
Consolidated Appropriations Act, 2024,
HRSA is awarding supplemental funds
in FY 2024 to two Regional Pediatric
Pandemic Network (RPPN) Program
recipients to increase activities to
coordinate among the Nation’s pediatric
hospitals and their communities to
prepare for and coordinate researchinformed responses to future
pandemics. The current RPPN program
period of performance ends on August
31, 2026.
SUMMARY:
E:\FR\FM\12AUN1.SGM
12AUN1
65639
Federal Register / Vol. 89, No. 155 / Monday, August 12, 2024 / Notices
Sara
Kinsman, MD, Director, Division of
Child, Adolescent & Family Health,
Maternal & Child Bureau, HRSA, at
SKinsman@hrsa.gov and 301–443–2250.
SUPPLEMENTARY INFORMATION:
Intended Recipient(s) of the Award:
Children’s National Medical Center in
FOR FURTHER INFORMATION CONTACT:
Maryland, and University Hospitals
Cleveland Medical Center in Ohio, as
listed in table I.
Amount of Non-Competitive Awards:
Two awards totaling up to $5,819,999.
Project Period: September 1, 2021, to
August 31, 2026.
Assistance Listing (CFDA) Number:
93.110.
Award Instrument: A supplement for
RPPN support services.
Authority: Section 42 U.S.C. 701(a)(2)
(title V, sec. 501(a)(2) of the Social
Security Act).
TABLE 1—RECIPIENTS AND SUPPLEMENT AWARD AMOUNTS
Grant No.
Award recipient name
U1IMC45814 ..................................................
U1IMC43532 ..................................................
Children’s National Medical Center ....................................................
University Hospitals Cleveland Medical Center .................................
Justification: Per Congressional Report
language accompanying the Further
Consolidated Appropriations Act, 2024,
(Pub. L. 118–47) approximately
$5,819,999 in supplemental funding is
being awarded in FY 2024 to the two
RPPN cooperative agreement recipients
to increase activities to coordinate
among the Nation’s pediatric hospitals
and their communities to prepare for
and coordinate research-informed
responses to future pandemics. This
funding will increase the RPPN’s
capacity to help the 10 pediatric
hospitals in the network to curate and
disseminate guidance; develop models;
increase the number of children’s
hospitals participating in preparedness
activities; and integrate RPPN into
existing HRSA regions for sustainability
and emergency coordination within the
regions.
Funds will be used for project
activities within the scope of the current
awards (as announced in the funding
opportunity HRSA–21–104) to improve
everyday pediatric emergency readiness
and pediatric pandemic preparedness.
Supplements will provide for the
expansion of activities within the
current scope of the program to (a)
increase partnerships with the
communities they serve, including
efforts to prevent and address
disparities; (b) improve and expand
pediatric emergency readiness and
preparedness of pre-hospital emergency
medical services, community emergency
City, state
Award amount
MD
OH
$4,158,048
1,661,951
departments, and inpatient settings; and
(c) accelerate real-time dissemination of
research-informed pediatric care. The
total amount provided through this
supplemental funding to the two
awardees will be $5,819,999, resulting
in a total amount for each awardee of
$11,358,048. Supplemental funding
amounts per awardee differ in order to
meet the congressional direction to
achieve parity between the two
awardees’ total funding levels.
Projects approved by HRSA under
this supplement are to be performed
from the date of award through August
31, 2025. Supplemental funding for
similar activities may be considered in
future years, subject to the availability
of funding for the activity and
satisfactory performance.
ACTION:
Carole Johnson,
Administrator.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2024–17821 Filed 8–9–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Extension and Supplemental
Award for Living Organ Donation
Reimbursement Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
Notice of non-competitive
extension with supplemental award.
HRSA is providing
supplemental award funds to the award
recipient under the Living Organ
Donation Reimbursement Program. This
action will extend the current period of
performance for the recipient by 12
months to ensure continued access to
lifesaving living organ transplants via
the National Living Donor Assistance
Center.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Arjun Naik, Public Health Analyst,
Division of Transplantation, Health
Systems Bureau, HRSA, at ANaik@
hrsa.gov and (301) 443–2568.
Intended Recipient of the Award:
University of Kansas, Medical Center
Research Institute, Inc.
Amount of Non-Competitive Award:
$2,400,000.
Period of Performance: September 1,
2019, to August 31, 2025.
Assistance Listing (CFDA) Number:
93.134.
Award Instrument: Non-competitive
extension with supplemental funds.
Authority: 42 U.S.C. 274f (section 377
of the Public Health Service Act, as
amended)
khammond on DSKJM1Z7X2PROD with NOTICES
TABLE 1—RECIPIENTS AND AWARD AMOUNTS
Grant No.
Award recipient name
City, state
U13HS33878 ........
University of Kansas, Medical Center Research Institute, Inc .............
Fairway, KS ...................................
Justification: HRSA is committed to
best serving the needs of patients on the
national organ transplant waiting list,
their families, donors and their families.
As part of this effort, HRSA is working
VerDate Sep<11>2014
17:30 Aug 09, 2024
Jkt 262001
to continue to strengthen the Living
Organ Donation Reimbursement
Program and increase equitable access
to living organ transplants, particularly
for medically underserved communities.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Award amount
$2,400,000
Extending the period of performance
will allow HRSA additional time to
publish a new notice of funding
opportunity to continue to improve
living donation while ensuring
E:\FR\FM\12AUN1.SGM
12AUN1
]]>Agencies
[Federal Register Volume 89, Number 155 (Monday, August 12, 2024)]
[Notices]
[Pages 65638-65639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17821]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Notice of Supplemental Funding for Regional Pediatric Pandemic
Network Award Recipients
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of supplemental funding.
-----------------------------------------------------------------------
SUMMARY: Per Congressional Report language accompanying the Further
Consolidated Appropriations Act, 2024, HRSA is awarding supplemental
funds in FY 2024 to two Regional Pediatric Pandemic Network (RPPN)
Program recipients to increase activities to coordinate among the
Nation's pediatric hospitals and their communities to prepare for and
coordinate research-informed responses to future pandemics. The current
RPPN program period of performance ends on August 31, 2026.
[[Page 65639]]
FOR FURTHER INFORMATION CONTACT: Sara Kinsman, MD, Director, Division
of Child, Adolescent & Family Health, Maternal & Child Bureau, HRSA, at
[email protected] and 301-443-2250.
SUPPLEMENTARY INFORMATION:
Intended Recipient(s) of the Award: Children's National Medical
Center in Maryland, and University Hospitals Cleveland Medical Center
in Ohio, as listed in table I.
Amount of Non-Competitive Awards: Two awards totaling up to
$5,819,999.
Project Period: September 1, 2021, to August 31, 2026.
Assistance Listing (CFDA) Number: 93.110.
Award Instrument: A supplement for RPPN support services.
Authority: Section 42 U.S.C. 701(a)(2) (title V, sec. 501(a)(2) of
the Social Security Act).
Table 1--Recipients and Supplement Award Amounts
----------------------------------------------------------------------------------------------------------------
Grant No. Award recipient name City, state Award amount
----------------------------------------------------------------------------------------------------------------
U1IMC45814............................... Children's National Medical MD $4,158,048
Center.
U1IMC43532............................... University Hospitals OH 1,661,951
Cleveland Medical Center.
----------------------------------------------------------------------------------------------------------------
Justification: Per Congressional Report language accompanying the
Further Consolidated Appropriations Act, 2024, (Pub. L. 118-47)
approximately $5,819,999 in supplemental funding is being awarded in FY
2024 to the two RPPN cooperative agreement recipients to increase
activities to coordinate among the Nation's pediatric hospitals and
their communities to prepare for and coordinate research-informed
responses to future pandemics. This funding will increase the RPPN's
capacity to help the 10 pediatric hospitals in the network to curate
and disseminate guidance; develop models; increase the number of
children's hospitals participating in preparedness activities; and
integrate RPPN into existing HRSA regions for sustainability and
emergency coordination within the regions.
Funds will be used for project activities within the scope of the
current awards (as announced in the funding opportunity HRSA-21-104) to
improve everyday pediatric emergency readiness and pediatric pandemic
preparedness. Supplements will provide for the expansion of activities
within the current scope of the program to (a) increase partnerships
with the communities they serve, including efforts to prevent and
address disparities; (b) improve and expand pediatric emergency
readiness and preparedness of pre-hospital emergency medical services,
community emergency departments, and inpatient settings; and (c)
accelerate real-time dissemination of research-informed pediatric care.
The total amount provided through this supplemental funding to the two
awardees will be $5,819,999, resulting in a total amount for each
awardee of $11,358,048. Supplemental funding amounts per awardee differ
in order to meet the congressional direction to achieve parity between
the two awardees' total funding levels.
Projects approved by HRSA under this supplement are to be performed
from the date of award through August 31, 2025. Supplemental funding
for similar activities may be considered in future years, subject to
the availability of funding for the activity and satisfactory
performance.
Carole Johnson,
Administrator.
[FR Doc. 2024-17821 Filed 8-9-24; 8:45 am]
BILLING CODE 4165-15-P
